Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT04601857
Title Futibatinib and Pembrolizumab Combination in the Treatment of Advanced or Metastatic Urothelial Carcinoma
Recruitment Active, not recruiting
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Taiho Oncology, Inc.
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | FRA | ESP

Facility Status City State Zip Country Details
UCSF Helen Diller Family Comprehensive Cancer Center San Francisco California 94158 United States Details
Dana Farber Cancer Institute Boston Massachusetts 02215 United States Details
Henry Ford Hospital Detroit Michigan 48202 United States Details
Comprehensive Care Centers of Nevada Las Vegas Nevada 89148 United States Details
ICANS - Institut de cancérologie de Strasbourg Europe Strasbourg Bas-Rhin 67200 France Details
Institut Paoli Calmettes - Hôpital de jour Marseille Bouches-du-Rhône 13273 France Details
Centre Georges-François Leclerc Dijon Côte d'Or 21079 France Details
Centre Leon Berard - departement d'oncologie medicale Lyon Rhone 69373 France Details
Centre Regional de Lutte Contre le Cancer de Lorraine Vandœuvre-lès-Nancy 54500 France Details
Institut De Cancerologie Gustave Roussy Villejuif 94805 France Details
ALTHAIA, Xarxa Assistencial Universitària de Manresa Manresa Brcelona 8243 Spain Details
Hospital Clinic de Barcelona Barcelona 08036 Spain Details
Hospital de La Santa Creu i Sant Pau Barcelona 8025 Spain Details
Hospital Universitario Vall d'Hebrón Barcelona 8035 Spain Details
Hospital Universitario Reina Sofia Córdoba 14004 Spain Details
Hospital Universitario HMN Sanchinarro Madrid 28050 Spain Details
Hospital Universitario Marqués de Valdecilla Santander 39008 Spain Details
Hospital la Fe Valencia 46026 Spain Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field